Inactive Instrument

Cesca Therapeutics Inc Share Price Nasdaq

Equities

US1571311034

Office Equipment

Sales 2024 * 16.86M 1.41B Sales 2025 * 21.11M 1.76B Capitalization 5.52M 460M
Net income 2024 * 2M 167M Net income 2025 * 5M 417M EV / Sales 2024 * 0.33 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.26 x
P/E ratio 2024 *
8.68 x
P/E ratio 2025 *
3.47 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 95.89%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 53 10/16/10
Director of Finance/CFO 51 01/10/01
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 69 24/17/24
Director/Board Member 78 10/17/10
Chief Executive Officer 53 10/16/10
More insiders
ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. It provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications include AXP Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large-Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory use and CAR-TXpress Platform for Clinical Manufacturing. AXP Automated Cell Separation System is an automated, fully closed cell separation system.
More about the company